Malignant mixed mesodermal tumours: biology and clinical aspects
- 31 July 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (11) , 1437-1446
- https://doi.org/10.1016/s0959-8049(02)00114-4
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Malignant mixed mullerian tumors of the ovary: histopathologic and clinical review of 36 casesInternational Journal of Gynecologic Cancer, 1999
- Results of Primary and Adjuvant Radiotherapy in the Treatment of Mixed Müllerian Tumors of the Corpus UteriGynecologic Oncology, 1999
- Evidence for a Common Etiology for Endometrial Carcinomas and Malignant Mixed Mullerian TumorsGynecologic Oncology, 1998
- Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumoursThe Journal of Pathology, 1997
- Progesterone Receptor Levels Independently Predict Survival in Endometrial AdenocarcinomaGynecologic Oncology, 1995
- Malignant mixed Müllerian tumors of the uterusInternational Journal of Gynecology & Obstetrics, 1994
- Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A Clinical, Pathologic, and Immunohistochemical Study of Three Cases and a Review of the LiteratureCancer, 1994
- A Phase II Trial of Ifosfamide and Mesna in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Ovary Previously Treated with Platinum-Based Chemotherapy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1994
- Carcinosarcoma of the SpleenThe American Journal of Surgical Pathology, 1994
- Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovaryGynecologic Oncology, 1989